Professional Documents
Culture Documents
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis.
Although we have taken great care prior to producing this presentation, it represents
BCG’s view at a particular point in time. BCG does not guarantee or make any
representation or warranty as to the accuracy, reliability, completeness, or currency
of the information in this document nor its usefulness in achieving any purpose. This
presentation is not intended to: (i) constitute medical or safety advice, nor be a
substitute for the same; nor (ii) be seen as a formal endorsement or
recommendation of a particular response. As such you are advised to make your own
assessment as to the appropriate course of action to take, using this presentation as
guidance. Please carefully consider local laws and guidance in your area, particularly
the most recent advice issued by your local (and national) health authorities, before
making any decision.
No recipient shall rely on this document for any purpose and BCG will not be liable
for any loss, damage, cost, or expense incurred or arising by reason of any person
using or relying on information in this document. BCG shall have no liability
whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document.
Receipt and review of this document shall be deemed agreement with and
consideration for the foregoing.
The summary is for internal use only and not for commercial use by the recipients.
No part may be reproduced in any form.
1
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
Agenda
COVID-19 evolution update
Businesses in the new normal: What do leaders expect going forward?
Impacts of COVID-19 on the healthcare sector
2
COVID-19 evolution update
3
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
GDP
Critical care
patients
Time
Note: Flags intended to illustrate each country phase and are not in scale.
Source: Johns Hopkins CSSE; Press search; IBGE; Google Community Mobility; BCG analysis 4
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
World 150,000
Copyright © 2020 by Boston Consulting Group. All rights reserved. Updated 16 June 2020 Version 10.1.
Africa
~984k cases
Asia1
~48k deaths 0
Mar Apr May Jun
Copyright © 2020 by Boston Consulting Group. All rights reserved. Updated 24 April 2020 Version 3.1.
400
~455k deaths
200
Brazil Peru
Brazil
100
US
~48k deaths 0
0 10 20 30 40 50 60 70 80 90 100 110 120 130
Days after 100th case
Note: Chile data as of June 16; Countries shown on the graph have more than 1.000 reported confirmed cases
Source: Johns Hopkins CSSE, United Nations, BCG Analysis 6
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVID Task Force Disclaimer: Reported cases may be
bcg.brazil.covid19@bcg.com
underestimated given low number of testing
New confirmed cases showing early sign Deaths by COVID-19 are growing at
of plateauing slower pace
New confirmed cases/1M habs New deaths by COVID-19/1M habs
(7 days moving average) (7 days moving average)
x.x Ratio of test per case
150 5.0
4.6
121.0 4.0
100
3.0
2.0
50
2.6
1.5 1.0
1.8
0 0.0
0 20 40 60 80 96 0 20 40 60 80 96
Days after 100th case Days after 100th case
Daily growth for
considered period 22% 6.3% 6.6% 4.5% 1.2% N/A 8.6% 7.0% 1.8% 0.3%
Note: Ministry of Health changed the way the number of cases and deaths are reported, creating uncertainty about the data. We're using data from States Health Secretaries whenever possible
to avoid inconsistencies; Number of testing are not updated on a daily manner. We're using a linear distribution between released dates for the ratio calculation.
Source: States Health Secretaries; IBGE; BCG analysis 7
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVID Task Force Disclaimer: Reported cases may be
bcg.brazil.covid19@bcg.com
underestimated given low number of testing
New confirmed cases showing early sign Deaths by COVID-19 are growing at
of plateauing slower pace
New confirmed cases/1M habs New deaths by COVID-19/1M habs
(7 days moving average) (7 days moving average)
150 6.0
5.3
100 4.0
93.7
50 2.0
0 0.0
0 20 40 60 80 96 0 20 40 60 80 96
Days after 100th case Days after 100th case
Daily growth for
considered period 16% 2.6% 4.5% 1.9% 1.5% N/A 5.2% 5.8% 1.4% 0.8%
Note: Ministry of Health changed the way the number of cases and deaths are reported, creating uncertainty about the data. We're using data from States Health Secretaries whenever possible
to avoid inconsistencies; Number of testing are not updated on a daily manner. We're using a linear distribution between released dates for the ratio calculation.
Source: States Health Secretaries; IBGE; BCG analysis 8
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVID Task Force Disclaimer: Reported cases may be
bcg.brazil.covid19@bcg.com underestimated given low number of testing
Data as of 18 June
45%
Higher growth but lower Higher demand of
! demand of health system health system
21% of GDP 56% of GDP 6% of GDP
30%
Active cases
AL doubling: 4 days
GO
Active cases
15% RO
SP ES RN RR2 doubling: 7 days
PR MS MT DF SE Active cases
TO PB
AC stability
0% SC PI
RS RJ MG AM MA AP
BA PA CE
Negative growth and lower PE
demand of health system
17% of GDP
-15%
0.1 1 5.0 10.0 20.0 100
Active cases / ICU Beds (log)
# of reported active cases
Note: Ministry of Health changed the way the number of cases and deaths are reported, creating uncertainty about the data. We're using data from States Health Secretaries whenever possible to avoid
inconsistencies; Active cases considers the confirmed cases excluding the people who have died or recovered. Number of people who recovered was not available in the state of GO and were computed using
the avg. % of recovered cases in Brazil. RN, MS and TO data as of June 10; 1. Based on study of 44,672 confirmed cases in Mainland China 2. RR active cases/beds is 190, plotted as 100 because of the scale
Source: States Health Secretaries; Press search; IBGE, China Center for Disease Control (CCDC); Worldometer; BCG Analysis 12
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVID Task Force Disclaimer: Reported cases may be
bcg.brazil.covid19@bcg.com underestimated given low number of testing
60%
Active cases
doubling: 4 days
Note: Ministry of Health changed the way the number of cases and deaths are reported, creating uncertainty about the data. We're using data from States Health Secretaries whenever possible to avoid
inconsistencies; Active cases considers the confirmed cases excluding the people who have died or recovered. Number of people who recovered was not available in the state of GO and were computed using the avg.
% of recovered cases in Brazil. RN, MS and TO data as of June 17; 1. Based on study of 44,672 confirmed cases in Mainland China 2. Active cases/beds is 225 in RR and 119 in AP, plotted as 100 because of the scale
Source: States Health Secretaries; Press search; IBGE, China Center for Disease Control (CCDC); Worldometer; BCG Analysis 13
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVID Task Force Disclaimer: Reported cases may be
bcg.brazil.covid19@bcg.com underestimated given low number of testing
60%
Active cases
doubling: 4 days
Note: Ministry of Health changed the way the number of cases and deaths are reported, creating uncertainty about the data. We're using data from States Health Secretaries whenever possible to avoid
inconsistencies; Active cases considers the confirmed cases excluding the people who have died or recovered. Number of people who recovered was not available in the state of GO and were computed using the avg.
% of recovered cases in Brazil. RN, MS and TO data as of June 17; 1. Based on study of 44,672 confirmed cases in Mainland China 2. Active cases/beds is 225 in RR and 119 in AP, plotted as 100 because of the scale
Source: States Health Secretaries; Press search; IBGE, China Center for Disease Control (CCDC); Worldometer; BCG Analysis 14
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
40 MT
Increasing
Increase of 5 p.p.
PR SE1
20 or more
MS BA
PI SP AL
MG RS RN1 Stabilizing
0 SC1 RO ES Less than 5 p.p. of
AM variation.
PB MA
CE PE
-20 PA Decreasing
RJ Decrease of 5 p.p.
or more
-40
0% 20% 40% 60% 80% 100%
Average occupancy rate of ICU beds from 14/06 to 17/06 (%)
15/06
Louisiana 3 4 6 8 11 16 21 23 32 37 47 59 68 78 83 88 118 142 210 232 282 291 333 339 326 281 275 231 233 189 161 151 131 119 110 102 108 103 102 99 93 90 87 78 75 74 70 79 81 79 80 83 84 81 66 70 69 66 63 70 87 92 83 87 89 92 82 93 95 86 84 95 93 98 71 58 81 84 78 83 81 85 98 89 89 83 88 89 89 92 117 117
First New York 4 6 10 21 39 59 82 112 146 177 204 236 268 299 322 336 368 390 401 427 451 466 478 470 493 509 509 493 484 469 464 466 455 428 415 399 387 371 321 292 301 328 328 320 305 305 300 270 226 208 198 192 178 170 162 148 139 133 127 123 114 113 111 108 105 105 101 98 91 86 84 84 81 78 75 74 71 68 66 68 67 62 58 56 54 52 47 45 42 40 39 38
affected
New Jersey 1 3 4 6 11 14 20 30 43 55 64 99 128 158 185 222 242 287 301 339 370 388 393 414 405 409 397 386 392 378 393 379 391 384 374 377 388 379 400 397 382 387 382 361 345 329 300 305 293 285 275 269 250 247 236 220 193 192 166 156 140 131 124 125 129 136 148 143 138 129 123 110 103 94 90 101 104 101 94 93 87 86 72 69 60 58 52 53 53 45 44 44
Massachusetts 2 3 4 3 5 6 8 10 12 20 33 43 59 77 89 103 113 122 136 148 155 156 168 178 188 207 219 231 269 270 269 272 274 290 292 274 277 283 284 301 346 356 354 353 360 365 342 284 276 281 271 258 256 251 243 231 215 208 201 189 189 180 183 183 190 190 186 174 166 151 149 141 131 120 111 105 106 99 92 90 86 80 76 70 62 58 57 53 54 52 47 45
Michigan 1 1 1 2 4 6 8 16 20 26 33 39 48 61 66 77 86 104 117 134 141 150 158 167 162 158 144 140 128 126 120 115 110 114 108 107 96 86 90 98 102 97 98 96 102 100 95 89 95 93 90 82 77 71 66 61 58 61 62 58 68 66 66 70 75 74 79 69 68 68 63 54 50 47 45 47 45 47 47 47 44 41 43 38 32 31 28 22 21 12 13 16
1 2 3 4 6 7 7 12 15 22 31 34 44 53 67 86 101 107 113 145 150 148 174 186 169 239 225 250 255 259 249 279 244 251 242 237 258 255 309 289 286 282 293 248 238 172 184 193 188 161 159 173 169 164 146 148 171 152 149 155 147 147 149 155 174 164 167 150 142 133 122 110 115 91 94 85 80 69 75 67 72 67 68 72 71 54 48 50 49 49 47 45
Connecticut
2 2 3 4 6 6 6 8 11 14 13 16 20 23 28 41 49 59 65 69 76 85 91 100 119 146 137 208 235 213 273 243 243 330 289 275 327 303 349 368 340 356 369 353 327 324 319 305 291 275 262 271 264 257 245 229 242 242 227 220 200 194 195 189 181 180 205 210 205 205 188 171 170 134 124 121 117 116 125 122 117 112 109 84 69 88 78 72 72 68 68 68
affected D.C.
0 1 1 2 2 3 4 5 6 7 8 11 15 19 24 27 31 37 41 47 50 56 62 64 84 91 99 108 109 116 121 106 109 109 109 109 112 112 112 117 119 129 135 137 140 144 142 162 158 163 164 166 173 180 166 167 168 165 164 157 154 154 152 147 151 177 177 180 176 178 177 175 145 144 146 155 154 153 146 153 155 145 137 129 123 120 112 106 103 91 90 88
Maryland 1 1 2 3 4 6 8 11 14 16 18 24 27 31 40 43 50 58 58 66 77 75 81 85 91 98 101 99 108 110 109 107 105 109 113 107 107 111 119 126 136 142 153 162 170 172 180 185 189 198 202 201 202 202 200 198 183 172 193 186 192 187 185 185 197 169 177 166 170 173 182 175 171 157 148 135 125 112 104 109 107 101 95 90 85 81 72 68 66 60 56 54
Illinois 1 1 2 3 4 5 6 7 9 13 15 15 18 25 26 29 32 37 39 42 56 65 76 89 110 120 129 130 140 143 146 132 126 145 155 134 145 147 174 182 165 152 219 208 241 213 209 217 214 172 165 117 165 177 175 182 157 187 201 172 188 185 186 204 191 190 182 171 170 144 167 161 151 132 115 104 131 101 94 91 90 84 79 62 65 54 49 50 53 59 56 47
Delaware 1 1 2 2 4 5 6 7 8 10 16 21 23 27 32 33 35 32 34 43 44 44 50 56 60 70 69 76 85 84 84 83 78 77 71 63 64 65 72 70 69 62 73 69 68 62 59 60 75 69 74 80 84 93 99 97 95 97 96 95 97 94 95 89 91 91 111 104 109 116 128 137 155 141 153 159 153 164 173 148 133 120 112 127 121 109 126 149 179 205 216 242
Alabama 0 1 1 2 2 4 6 10 11 14 16 21 24 25 26 29 30 33 33 37 38 42 43 47 45 52 53 57 55 58 56 65 65 64 64 72 75 78 74 73 79 84 79 76 78 80 80 85 83 79 86 90 89 90 90 93 94 86 82 80 86 82 84 86 84 86 90 83 88 90 94 97 97 100 103 104 107 109 110 111 109 105 95 87 84 97 100 104 92 111 111 108
Recently Mississipi 1 1 1 2 3 4 6 8 12 15 17 20 23 25 28 27 34 42 40 37 38 40 39 37 30 34 38 38 39 38 35 31 32 29 30 33 34 33 33 44 52 54 54 56 56 62 52 66 73 73 76 76 75 70 53 44 38 41 51 51 54 53 52 50 52 48 43 47 51 53 58 53 52 60 57 56 58 51 42 72 74 73 75 76 82 93 68 65 66 72 71 81
affected Tennessee 1 1 2 2 3 4 5 6 10 12 13 15 17 22 25 24 26 24 31 35 37 39 39 38 43 34 38 35 31 31 30 31 37 31 32 34 38 39 40 41 44 46 47 46 47 47 47 47 46 47 48 49 49 47 49 50 48 47 44 46 46 44 43 44 46 48 49 50 51 53 51 51 49 44 47 54 57 63 66 70 80 84 89 101 101 104 105 105 109 104 97 100
S. Carolina 0 0 0 1 1 2 3 3 3 4 5 6 7 9 11 12 14 15 17 19 20 22 24 25 27 30 31 32 32 31 30 30 28 28 28 28 27 27 27 28 29 27 28 27 28 29 30 30 33 35 37 37 38 36 37 37 36 38 37 40 42 42 45 45 42 45 43 42 39 36 37 36 33 34 36 36 39 43 45 50 51 50 57 58 53 54 54 59 60 61 61 65
0 500+
1. 7-day rolling average of daily new case per 1M inhab. Peak: ~70 ~128 ~170
Source: Johns Hopkins CSSE; BCG analysis 18
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
Some states are experiencing a late first … while others have a second wave
peak in number of cases… pattern, but case count is low so far
Daily new cases¹ Daily new cases¹
Ph 1 Ph 2
200 30.04. 15.05. 200 03.04. 04.05. 05.06.
Arizona Florida
100 100
0 0
Daily new cases¹ Daily new cases
Ph 1 Ph 2 Ph 1 Ph 2
200 07.04. 20.04. 18.05. 200 13.04. 30.04. 22.05.
S. Carolina Tennessee
100 100
0 0
Daily new cases¹ Daily new cases¹
Ph 1 Ph 2 Ph 1 Ph 2
200 200
17.04.² 01.05. 14.05. 02.04. 04.05. 23.05.
Utah Washington
100 100
0 0
01.03. 01.04. 01.05. 01.06. 01.07. 01.03. 01.04. 01.05. 01.06. 01.07.
Arizona
Florida
300 50% 300 50% 300 50%
0 0% 0 0% 0 0%
Daily new cases¹ Positivity² Daily new cases¹ Positivity² Daily new cases¹ Positivity²
600 100% 600 100% 600 100%
New Jersey
Tennessee
Carolina
South
300 50% 300 50% 300 50%
0 0% 0 0% 0 0%
Daily new cases¹ Positivity² Daily new cases¹ Positivity² Daily new cases¹ Positivity²
Massachusetts
Washington
Utah
0 0% 0 0% 0 0%
01.03. 01.05. 01.07. 01.03. 01.05. 01.07. 01.03. 01.05. 01.07.
Daily new cases Positivity
1. 7-day rolling average of daily new cases per 1M inhab. 2. Positivity defined as the number of positive cases per total tests realized; calculated as 7-day rolling average
Source: Johns Hopkins CSSE; The COVID Tracking Project; BCG analysis 23
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
Schools Schools remain closed until the end of 2019-20 academic year
Gyms & Sport
activities²
Personal Services²
Place of Worship²
Retail
(non-essential)³
Parks
Limit on Gathering Max. 10 Max. 10 Max. 10 No Max. 3 Max. 50 Max. 50 Max. 50 Max. 5
Social
Rules
Mask requirement Recommended Required⁴ Required⁴ No⁵ No Recommended Recommended Recommended Recommended
Note: Countries with open borders are open to any European country, however restrictions can still be imposed. Countries with partially open borders are accepting visitors only from specific
EU countries 1. Portugal's land border with Spain set to reopen only on July 01. Source: Press search; BCG analysis 28
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
Selected examples
Virus is still circulating
The number of new daily cases are under control, but hundreds
of new cases are still being reported everyday by major
European countries
Europe: Life
is going back
to normal, Still far from herd immunity
Herd immunity is estimated to be reached when 50-90% of population
however a has antibodies. Only 11.3% of Madrid citizens are estimated to have
2nd wave risk antibodies for COVID-191
is still
possible
No vaccine available yet
Oxford vaccine, only one in phase 3 yet, will not be available at least
until October. Clinical trials are still underway to prove that the
vaccine is safe and efficient
• All arriving passengers (~95k/day) go • People arriving in Hong Kong has to • On June 12 a seafood supermarket was
through a health questionnaire wear tracking bracelets for 2 weeks to closed in Beijing after 36 new cases were
• Suspected cases are tested; results ensure to compliance with the 14 days linked to it
ready in a few minutes and positive quarantine • On June 15, 21 residential communities
cases transferred to hospitals • In China the use of the app is enforced and a second seafood supermarket were
• Negative cases install app and self- by limiting basic actions(e.g. access to closed
report/self-quarantine for 14 days public transport) without a QR code • On June 17, authorities imposed citywide
generated in the app movement restrictions
Source: Foreign Affairs: South Korea Offers a Lesson in Best Practices, 10 April 2020; The Straits Times: South Korea dials up coronavirus testing; Testing on
the move: South Korea's rapid response to the COVID-19 pandemic, David Lee and Jaehong Lee, May 2020; Press search; BCG analysis 30
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
Brazil showing early signs of outbreak stabilization in number of
new cases and new deaths
31
Business in the new normal: What
do leaders expect going forward?
32
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
Immediate
impact on business
Permanent business
Environment changes
Note: Survey dimensions are: Magnitude and length of financial impact, Major pain-points and support required, Health & safety measures taken, Business
continuity measures and recession preparedness, Opportunities & long-term structural enhancements 33
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
Actions
Social-distancing measures
88% 11%
in customer/employee contact areas 2%
Increased adoption of
83% 15% 3%
digital/contactless procedures
Legend
Have Taken Plan to Take Not Planned
37%
25%
16%
13%
of Brazilians
bought online
Shift in marketing channel effectiveness 46% 36% 18% for the first
time in 2020
Trading up/down within product categories 23% 47% 31%
Legend
Persistent Change Temporary Change No Change
Source: BCG COVID-19 Company Survey; BCG Henderson Institute Analysis, Iinterativa, Conversion 36
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVID Task Force Permanent
bcg.brazil.covid19@bcg.com
Changes
Permanent changes to business structures and processes Examples of companies embracing changes caused by COVID-19
73%
Remote-working and meeting policies
96%
+32% Implemented/implementing WFH
68%
Crisis response procedures +1%
69%
45%
Travel policies +53%
69%
20%
Marketing, media and advertising plans +165%
53%
34%
Employee communication policies +44%
49%
41
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
42
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
Source: Sistema de Informações de Beneficiários-SIB/ANS/MS, Cadastro Geral de Empregados e Desempregados – CAGED, BCG analysis 43
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
As the public health may face an … and tax collection declines public
increased patient inflow… health spending may be pressured
Total accumulated tax collection¹ (R$ B)
Pent up demand for non-urgent care
600
-4,2%
Cancer and chronic patients without treatment
or early diagnosis are getting more serious and
400
may consume more resources
524,4 502,3
Shift from private to public healthcare system 200
due to the economical crisis
0
Social isolation and financial crisis can effect Jan - Apr/2019 Jan - Apr/2020
mental health, increasing number of depressed
1. Does not account for inflation
Source: Receita Federal; press search; BCG analysis 44
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
1. Estimated decrease since beginning of pandemics in Private and Philantropic Hospitals 2. Estimated decrease in exams performed in March and April 2020
in comparison with same period in 2019
Source: ANAHP (Associação Nacional de Hospitais Privados); Abramed (Associação Brasileira de Medicina Diagnóstica) 45
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVIDBCGTask
BrazilForce
COVID Task Force
bcg.brazil.covid19@bcg.com
bcg.brazil.covid19@bcg.com
Death
2 Death 1 10 Unemployment 1
Fear
Insecurity 4 Worry 4 12 Insecurity 6
Crisis vaccine 5 Virus 1 13 Health 9
sadness
pandemic isolation 6 Disease 6 14 Quarantine 11
disease unemployment Sadness 2 Vaccine
quarantine Virus
7 15
8 Pandemic 3 16 Risk 3
Question text: “What comes to your mind when you think about the corona virus?”. Similar responses categorized together.
Source: BCG COVID-19 Consumer Sentiment Survey – BR: May 10–11, 2020 (N = 1,318, weighted) 47
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVIDBCGTask
BrazilForce
COVID Task Force
bcg.brazil.covid19@bcg.com
bcg.brazil.covid19@bcg.com
Vaccine available 66 44 49 53 60 57
Treatment available 42 35 36 48 38 41
No new cases 37 27 32 40 40 38
Less cases 36 41 40 33 47 26
More tests available 32 26 20 27 32 24
No gov. restrictions 18 23 38 30 29 20
Already comfortable 17
1. Option text: "Local leisure activities like movies, theaters and bars"
Source: BCG COVID-19 Consumer Sentiment Survey – BR: May 10–11, 2020 (N = 1,318, weighted) 48
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
and Accelerated trend toward Shift away from centralized, general care
engagement decentralization of care hospitals to specialty & ambulatory clinics
Increase in self-diagnosing
models Increase in home delivery and home care
51
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
CONFIDENTIAL. These analyses represent only findings based on discrete data from one point in time
(April 6-12, 2020) . They are not intended as a prediction or forecast, and the situation is changing daily
1. Survey conducted by Associação Paulista de Medicina, from Apr 9th to Apr 17th, N = 2.312
Source: Press search, BCG analysis 55
BCG Brazil COVID Task Force CONFIDENTIAL. These analyses represent only findings based on discrete data from one point in time
bcg.brazil.covid19@bcg.com (May 1-14, 2020) . They are not intended as a prediction or forecast, and the situation is changing daily
Patients struggle to use tools 4,8 4,0 4,9 4,4 4,2 4,7 5,9
5,2
4,6
Difficult connecting with patients 3,9 4,0 5,1 3,2 5,3 3,3 2,1
2,6
Patients don’t want to 3,1 3,2 3,9 4,3 2,9 3,2 1,6
4,0
Safety / privacy concerns 2,6 1,7 1,9 2,3 3,5 2,5 2,0
2,8
Reimbursement is
2,6 3,7 1,5 2,3 2,6 2,2 2,9
not reliable or available 2,9
Dont have the right tools 2,4 2,3 2,7 1,6 2,1 1,6 4,0
2,1
Operational processes and
2,1 1,6 2,3 2,9 1,0 2,6 2,0 1,1
workflows are not in place or are challenging
Question: What are your biggest pain points when interacting with patients virtually?
MedTech COVID-19 Response Survey, May 2020; BCG analysis 56
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
structure
Increased investments in Investments in R&D platforms for vaccines &
(some) HC infrastructure diagnostics tests
Monitoring & fast-response systems
Emergency capacity for future crises (e.g.
campaign hospitals, rapid deployment services)
57
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
at LinkedIn BCG.Brazil.Covid19@bcg.com
58
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
BCG Brazil COVID Task Force
bcg.brazil.covid19@bcg.com
59
The situation surrounding COVID-19 is dynamic and rapidly evolving, on a daily basis. Although we have taken great care prior to producing this presentation, it represents BCG’s view at a particular point in time. BCG does not guarantee or make any representation or warranty as to the accuracy, reliability, completeness, or currency of the information in this document nor its usefulness in achieving any purpose.
This presentation is not intended to: (i) constitute medical or safety advice, nor be a substitute for the same; nor (ii) be seen as a formal endorsement or recommendation of a particular response. As such you are advised to make your own assessment as to the appropriate course of action to take, using this presentation as guidance. Please carefully consider local laws and guidance in your area, particularly the most
recent advice issued by your local (and national) health authorities, before making any decision. No recipient shall rely on this document for any purpose and BCG will not be liable for any loss, damage, cost, or expense incurred or arising by reason of any person using or relying on information in this document. BCG shall have no liability whatsoever to any party, and any person using this document hereby waives any
rights and claims it may have at any time against BCG with regard to the document. Receipt and review of this document shall be deemed agreement with and consideration for the foregoing. The summary is for internal use only and not for commercial use by the recipients. No part may be reproduced in any form.
bcg.com